273 related articles for article (PubMed ID: 24588402)
21. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.
Shehadeh J; Fernandes HB; Zeron Mullins MM; Graham RK; Leavitt BR; Hayden MR; Raymond LA
Neurobiol Dis; 2006 Feb; 21(2):392-403. PubMed ID: 16165367
[TBL] [Abstract][Full Text] [Related]
22. Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.
Xu J; Kurup P; Zhang Y; Goebel-Goody SM; Wu PH; Hawasli AH; Baum ML; Bibb JA; Lombroso PJ
J Neurosci; 2009 Jul; 29(29):9330-43. PubMed ID: 19625523
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A.
Metzler M; Gan L; Mazarei G; Graham RK; Liu L; Bissada N; Lu G; Leavitt BR; Hayden MR
J Neurosci; 2010 Oct; 30(43):14318-29. PubMed ID: 20980587
[TBL] [Abstract][Full Text] [Related]
24. Oxidative metabolism and Ca
Hamilton J; Brustovetsky T; Brustovetsky N
Neurochem Int; 2017 Oct; 109():24-33. PubMed ID: 28062223
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells.
Gines S; Ivanova E; Seong IS; Saura CA; MacDonald ME
J Biol Chem; 2003 Dec; 278(50):50514-22. PubMed ID: 14522959
[TBL] [Abstract][Full Text] [Related]
26. C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.
Back MK; Kurzawa J; Ruggieri S; von Engelhardt J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884469
[TBL] [Abstract][Full Text] [Related]
27. Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease.
Hong C; Seo H; Kwak M; Jeon J; Jang J; Jeong EM; Myeong J; Hwang YJ; Ha K; Kang MJ; Lee KP; Yi EC; Kim IG; Jeon JH; Ryu H; So I
Brain; 2015 Oct; 138(Pt 10):3030-47. PubMed ID: 26133660
[TBL] [Abstract][Full Text] [Related]
28. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.
Kolodziejczyk K; Raymond LA
Neurobiol Dis; 2016 Feb; 86():62-74. PubMed ID: 26621114
[TBL] [Abstract][Full Text] [Related]
29. DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease.
Schmidt ME; Caron NS; Aly AE; Lemarié FL; Dal Cengio L; Ko Y; Lazic N; Anderson L; Nguyen B; Raymond LA; Hayden MR
Front Cell Neurosci; 2020; 14():590569. PubMed ID: 33250715
[TBL] [Abstract][Full Text] [Related]
30. Dantrolene is neuroprotective in Huntington's disease transgenic mouse model.
Chen X; Wu J; Lvovskaya S; Herndon E; Supnet C; Bezprozvanny I
Mol Neurodegener; 2011 Nov; 6():81. PubMed ID: 22118545
[TBL] [Abstract][Full Text] [Related]
31. Functional adaptation of the N-methyl-D-aspartate receptor to inhibition by ethanol is modulated by striatal-enriched protein tyrosine phosphatase and p38 mitogen-activated protein kinase.
Wu PH; Coultrap SJ; Browning MD; Proctor WR
Mol Pharmacol; 2011 Sep; 80(3):529-37. PubMed ID: 21680777
[TBL] [Abstract][Full Text] [Related]
32. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
Graham RK; Pouladi MA; Joshi P; Lu G; Deng Y; Wu NP; Figueroa BE; Metzler M; André VM; Slow EJ; Raymond L; Friedlander R; Levine MS; Leavitt BR; Hayden MR
J Neurosci; 2009 Feb; 29(7):2193-204. PubMed ID: 19228972
[TBL] [Abstract][Full Text] [Related]
33. PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61.
Won S; Incontro S; Nicoll RA; Roche KW
Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4736-44. PubMed ID: 27457929
[TBL] [Abstract][Full Text] [Related]
34. Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease.
Silva AC; Ferreira IL; Hayden MR; Ferreiro E; Rego AC
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):34-44. PubMed ID: 28939435
[TBL] [Abstract][Full Text] [Related]
35. Altered Regulation of Striatal Neuronal
Kang R; Wang L; Sanders SS; Zuo K; Hayden MR; Raymond LA
Front Synaptic Neurosci; 2019; 11():3. PubMed ID: 30846936
[No Abstract] [Full Text] [Related]
36. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.
Zeron MM; Fernandes HB; Krebs C; Shehadeh J; Wellington CL; Leavitt BR; Baimbridge KG; Hayden MR; Raymond LA
Mol Cell Neurosci; 2004 Mar; 25(3):469-79. PubMed ID: 15033175
[TBL] [Abstract][Full Text] [Related]
37. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
38. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.
Puddifoot C; Martel MA; Soriano FX; Camacho A; Vidal-Puig A; Wyllie DJ; Hardingham GE
J Neurosci; 2012 May; 32(20):6995-7000. PubMed ID: 22593067
[TBL] [Abstract][Full Text] [Related]
39. Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease.
Benn CL; Slow EJ; Farrell LA; Graham R; Deng Y; Hayden MR; Cha JH
Neuroscience; 2007 Jun; 147(2):354-72. PubMed ID: 17544587
[TBL] [Abstract][Full Text] [Related]
40. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
Schmidt ME; Buren C; Mackay JP; Cheung D; Dal Cengio L; Raymond LA; Hayden MR
BMC Biol; 2018 Jun; 16(1):58. PubMed ID: 29945611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
